A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Clinical trial NCT05457283 · RECRUITING
Trial details
- NCT number
- NCT05457283
- Sponsor
- Bayer
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-08
- Primary completion
- 2028-11-28
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.